Bhat Laxminarayan
Reviva Pharmaceuticals Holdings, Inc. · President and CEO
Bhat Laxminarayan is listed in public filings as director, officer: President and CEO. This Bhat Laxminarayan insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Reviva Pharmaceuticals Holdings, Inc. (RVPH). Investors use Bhat Laxminarayan's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $204k109.2k shares | Grant / ExerciseMar 18, 2026 | $204.1K109.2k shares | $1.87 | -- | |
| $77k40.9k shares | Grant / ExerciseMar 18, 2026 | $76.5K40.9k shares | $1.87 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $934k519k shares | Grant / ExerciseFeb 13, 2025 | $934.2K519k shares | $1.80 | -- | |
| $327k181.5k shares | Grant / ExerciseFeb 13, 2025 | $326.7K181.5k shares | $1.80 | -- | |
| $190k158.5k shares | Grant / ExerciseSep 15, 2024 | $190.1K158.5k shares | $1.20 | -- | |
| $93k77.8k shares | Grant / ExerciseSep 15, 2024 | $93.4K77.8k shares | $1.20 | -- |